MED logo

Medifast (MED) EBITDA

Annual EBITDA

$139.51 M
-$56.23 M-28.73%

December 31, 2023

Summary

Performance

1-Year Change

-28.73%

3-Year Change

+0.75%

5-Year Change

+89.81%

15-Year Change

+218.22%

MED EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

57.89%
MED annual EBITDA is higher than 57.89% of companies in Consumer Cyclical sector

High & Low

All-time High

$223.05 M
MED annual EBITDA is currently -37.45% below its historical high of $223.05 million

3-Year Low

$139.51 M
MED annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
MED previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 20, 2025
MED next annual earnings announcement is scheduled for Feb 20, 2025

OtherMEDprofitabilitymetrics:

Annual Revenue

$1.07 B
MED annual revenue is $1.07 billion

Annual Net Income

$99.42 M
MED annual net profit is $99.42 million

Annual EBIT

$126.40 M
MED annual earnings before interest & taxes is $126.40 million

Annual EPS

$9.10
MED annual earnings per share is $9.10

Quarterly EBITDA

$5.30 M
+$10.11 M+210.21%

September 30, 2024

Summary

Performance

3-Month Change

+210.21%

1-Year Change

+210.21%

3-Year Change

-90.64%

5-Year Change

-75.99%

MED Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.06%
MED quarterly EBITDA is higher than 35.06% of companies in Consumer Cyclical sector

High & Low

All-time High

$62.74 M
MED quarterly EBITDA is currently -91.55% below its historical high of $62.74 million

3-Year Low

-$4.81 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MED previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 20, 2025
MED next earnings announcement is scheduled for Feb 20, 2025

OtherMEDprofitabilitymetrics:

Quarterly Revenue

$140.16 M
MED quarterly revenue is $140.16 million

Quarterly Net Income

$1.13 M
MED quarterly net profit is $1.13 million

Quarterly EBIT

$2.11 M
MED quarterly earnings before interest & taxes is $2.11 million

Quarterly EPS

$0.10
MED quarterly earnings per share is $0.10

TTM EBITDA

$23.72 M
-$23.62 M-49.89%

September 30, 2024

Summary

Performance

3-Month Change

-49.89%

1-Year Change

-49.89%

3-Year Change

-88.77%

5-Year Change

-75.33%

MED TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.98%
MED TTM EBITDA is higher than 35.98% of companies in Consumer Cyclical sector

High & Low

All-time High

$226.63 M
MED TTM EBITDA is currently -89.53% below its historical high of $226.63 million

3-Year Low

$23.72 M
MED TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MED previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 20, 2025
MED next earnings announcement is scheduled for Feb 20, 2025

OtherMEDprofitabilitymetrics:

TTM Revenue

$674.48 M
MED TTM revenue is $674.48 million

TTM Net Income

$7.33 M
MED TTM net profit is $7.33 million

TTM EBIT

$10.85 M
MED TTM earnings before interest & taxes is $10.85 million

TTM EPS

$0.61
MED TTM earnings per share is $0.61

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$139.51 M
MED annual EBITDA is $139.51 million

Annual Net Income

$99.42 M
MED annual net profit is $99.42 million

Annual Interest Expense

-
MED annual interest expense value is unknown

Annual Income Tax

$29.38 M
MED annual income tax is $29.38 million

Annual D&A

$13.11 M
MED annual depreciation & amortization is $13.11 million

MED EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-28.7%+210.2%-49.9%
3 y3 years+0.8%-90.6%-88.8%
5 y5 years+89.8%-76.0%-75.3%

MED EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-37.5%at low-90.8%+210.2%-89.5%at low
5 y5-year-37.5%+45.8%-91.5%+210.2%-89.5%at low
alltimeall time-37.5%+6264.8%-91.5%+210.2%-89.5%+6744.5%

Medifast EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$5.30 M(-210.2%)
$23.72 M(-49.9%)
Jun 2024
-
-$4.81 M(-142.9%)
$47.34 M(-49.8%)
Mar 2024
-
$11.20 M(-6.9%)
$94.22 M(-32.5%)
Dec 2023
$139.51 M(-28.7%)
$12.03 M(-58.4%)
$139.51 M(-14.4%)
Sep 2023
-
$28.92 M(-31.3%)
$162.99 M(-11.9%)
Jun 2023
-
$42.07 M(-25.5%)
$185.07 M(-4.9%)
Mar 2023
-
$56.48 M(+59.1%)
$194.69 M(-0.5%)
Dec 2022
$195.74 M(-12.2%)
$35.51 M(-30.4%)
$195.72 M(-6.8%)
Sep 2022
-
$51.01 M(-1.3%)
$209.99 M(-2.6%)
Jun 2022
-
$51.70 M(-10.1%)
$215.58 M(-4.9%)
Mar 2022
-
$57.52 M(+15.6%)
$226.63 M(+1.6%)
Dec 2021
$223.05 M(+61.1%)
$49.77 M(-12.1%)
$223.03 M(+5.6%)
Sep 2021
-
$56.60 M(-9.8%)
$211.23 M(+5.1%)
Jun 2021
-
$62.74 M(+16.4%)
$200.97 M(+19.5%)
Mar 2021
-
$53.92 M(+42.0%)
$168.15 M(+20.6%)
Dec 2020
$138.47 M(+44.8%)
$37.97 M(-18.1%)
$139.42 M(+16.0%)
Sep 2020
-
$46.34 M(+54.9%)
$120.16 M(+25.3%)
Jun 2020
-
$29.92 M(+18.8%)
$95.89 M(+0.9%)
Mar 2020
-
$25.19 M(+34.7%)
$95.01 M(-1.2%)
Dec 2019
$95.66 M(+30.2%)
$18.71 M(-15.2%)
$96.14 M(-2.0%)
Sep 2019
-
$22.07 M(-24.0%)
$98.15 M(+4.0%)
Jun 2019
-
$29.04 M(+10.3%)
$94.37 M(+12.9%)
Mar 2019
-
$26.32 M(+27.0%)
$83.59 M(+13.7%)
Dec 2018
$73.50 M(+67.6%)
$20.72 M(+13.2%)
$73.50 M(+16.2%)
Sep 2018
-
$18.30 M(+0.2%)
$63.27 M(+12.4%)
Jun 2018
-
$18.25 M(+12.5%)
$56.29 M(+11.7%)
Mar 2018
-
$16.23 M(+54.7%)
$50.38 M(+14.9%)
Dec 2017
$43.84 M(+35.9%)
$10.49 M(-7.3%)
$43.84 M(+6.5%)
Sep 2017
-
$11.31 M(-8.4%)
$41.16 M(+2.9%)
Jun 2017
-
$12.35 M(+27.5%)
$40.01 M(+17.4%)
Mar 2017
-
$9.69 M(+24.0%)
$34.07 M(+5.6%)
Dec 2016
$32.26 M(-9.9%)
$7.81 M(-23.2%)
$32.26 M(+1.8%)
Sep 2016
-
$10.17 M(+58.6%)
$31.68 M(+1.5%)
Jun 2016
-
$6.41 M(-18.6%)
$31.23 M(-11.5%)
Mar 2016
-
$7.88 M(+9.0%)
$35.29 M(-1.4%)
Dec 2015
$35.80 M(-6.5%)
$7.22 M(-25.6%)
$35.80 M(+2.8%)
Sep 2015
-
$9.71 M(-7.2%)
$34.83 M(+3.6%)
Jun 2015
-
$10.47 M(+24.8%)
$33.62 M(-4.1%)
Mar 2015
-
$8.39 M(+34.0%)
$35.05 M(-8.5%)
Dec 2014
$38.30 M(-17.3%)
$6.26 M(-26.4%)
$38.30 M(-12.7%)
Sep 2014
-
$8.50 M(-28.6%)
$43.88 M(-3.4%)
Jun 2014
-
$11.90 M(+2.2%)
$45.42 M(-2.8%)
Mar 2014
-
$11.64 M(-1.7%)
$46.75 M(+0.9%)
Dec 2013
$46.31 M(+30.4%)
$11.84 M(+17.9%)
$46.32 M(+10.0%)
Sep 2013
-
$10.04 M(-24.1%)
$42.12 M(-4.4%)
Jun 2013
-
$13.23 M(+18.1%)
$44.04 M(+15.2%)
Mar 2013
-
$11.21 M(+46.6%)
$38.22 M(+7.6%)
Dec 2012
$35.52 M(-0.6%)
$7.64 M(-36.1%)
$35.52 M(+11.2%)
Sep 2012
-
$11.96 M(+61.4%)
$31.94 M(+10.8%)
Jun 2012
-
$7.41 M(-13.0%)
$28.83 M(-11.3%)
Mar 2012
-
$8.52 M(+109.7%)
$32.49 M(-9.0%)
Dec 2011
$35.73 M
$4.06 M(-54.1%)
$35.73 M(-6.9%)
DateAnnualQuarterlyTTM
Sep 2011
-
$8.84 M(-20.1%)
$38.35 M(-4.2%)
Jun 2011
-
$11.07 M(-5.8%)
$40.05 M(+1.0%)
Mar 2011
-
$11.75 M(+75.7%)
$39.65 M(+5.7%)
Dec 2010
$37.50 M(+57.3%)
$6.69 M(-36.5%)
$37.50 M(+2.9%)
Sep 2010
-
$10.54 M(-1.3%)
$36.45 M(+11.2%)
Jun 2010
-
$10.68 M(+11.2%)
$32.77 M(+16.2%)
Mar 2010
-
$9.60 M(+70.3%)
$28.19 M(+18.3%)
Dec 2009
$23.84 M(+86.4%)
$5.64 M(-17.8%)
$23.84 M(+15.1%)
Sep 2009
-
$6.86 M(+12.5%)
$20.70 M(+18.9%)
Jun 2009
-
$6.09 M(+16.2%)
$17.41 M(+16.9%)
Mar 2009
-
$5.25 M(+109.4%)
$14.89 M(+16.4%)
Dec 2008
$12.79 M(+39.2%)
$2.50 M(-29.8%)
$12.79 M(+6.4%)
Sep 2008
-
$3.57 M(-0.1%)
$12.02 M(+10.4%)
Jun 2008
-
$3.58 M(+13.8%)
$10.89 M(+12.1%)
Mar 2008
-
$3.14 M(+81.0%)
$9.71 M(+2.1%)
Dec 2007
$9.19 M(-12.6%)
$1.74 M(-28.8%)
$9.51 M(-0.6%)
Sep 2007
-
$2.44 M(+1.7%)
$9.57 M(+1.1%)
Jun 2007
-
$2.40 M(-18.5%)
$9.46 M(-2.7%)
Mar 2007
-
$2.94 M(+64.1%)
$9.73 M(-8.5%)
Dec 2006
$10.51 M(+80.7%)
$1.79 M(-23.2%)
$10.63 M(+7.0%)
Sep 2006
-
$2.33 M(-12.3%)
$9.94 M(+6.3%)
Jun 2006
-
$2.66 M(-30.8%)
$9.35 M(+12.9%)
Mar 2006
-
$3.85 M(+250.3%)
$8.28 M(+42.4%)
Dec 2005
$5.82 M(+38.0%)
$1.10 M(-37.0%)
$5.82 M(+4.0%)
Sep 2005
-
$1.74 M(+9.6%)
$5.59 M(+17.9%)
Jun 2005
-
$1.59 M(+15.1%)
$4.75 M(+8.5%)
Mar 2005
-
$1.38 M(+57.8%)
$4.37 M(+3.8%)
Dec 2004
$4.21 M(-0.8%)
$876.00 K(-2.2%)
$4.21 M(+2.7%)
Sep 2004
-
$896.00 K(-26.6%)
$4.10 M(+1.0%)
Jun 2004
-
$1.22 M(-0.2%)
$4.06 M(+3.6%)
Mar 2004
-
$1.22 M(+59.7%)
$3.92 M(-7.6%)
Dec 2003
$4.25 M(+104.8%)
$765.00 K(-10.7%)
$4.25 M(+17.0%)
Sep 2003
-
$857.00 K(-20.6%)
$3.63 M(+0.4%)
Jun 2003
-
$1.08 M(-30.2%)
$3.62 M(+10.8%)
Mar 2003
-
$1.54 M(+936.9%)
$3.26 M(+57.5%)
Dec 2002
$2.07 M(+116.8%)
$149.00 K(-82.3%)
$2.07 M(+0.9%)
Sep 2002
-
$842.00 K(+15.7%)
$2.06 M(+46.5%)
Jun 2002
-
$728.00 K(+105.6%)
$1.40 M(+44.0%)
Mar 2002
-
$354.00 K(+170.2%)
$974.00 K(-8.9%)
Dec 2001
$956.00 K(+35.8%)
$131.00 K(-31.1%)
$1.07 M(-14.7%)
Sep 2001
-
$190.00 K(-36.5%)
$1.25 M(+5.9%)
Jun 2001
-
$299.00 K(-33.4%)
$1.18 M(+27.2%)
Mar 2001
-
$449.00 K(+42.5%)
$930.00 K(+32.1%)
Dec 2000
$704.00 K(-138.4%)
$315.00 K(+162.3%)
$704.00 K(+81.0%)
Sep 2000
-
$120.10 K(+161.7%)
$389.00 K(+44.7%)
Jun 2000
-
$45.90 K(-79.4%)
$268.90 K(+20.6%)
Mar 2000
-
$223.00 K(-162.5%)
$223.00 K(-162.5%)
Dec 1999
-$1.83 M(+439.1%)
-
-
Mar 1999
-
-$357.00 K
-$357.00 K
Dec 1998
-$340.00 K(-85.0%)
-
-
Dec 1997
-$2.26 M(-304.4%)
-
-
Dec 1996
$1.11 M
-
-

FAQ

  • What is Medifast annual EBITDA?
  • What is the all time high annual EBITDA for Medifast?
  • What is Medifast annual EBITDA year-on-year change?
  • What is Medifast quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Medifast?
  • What is Medifast quarterly EBITDA year-on-year change?
  • What is Medifast TTM EBITDA?
  • What is the all time high TTM EBITDA for Medifast?
  • What is Medifast TTM EBITDA year-on-year change?

What is Medifast annual EBITDA?

The current annual EBITDA of MED is $139.51 M

What is the all time high annual EBITDA for Medifast?

Medifast all-time high annual EBITDA is $223.05 M

What is Medifast annual EBITDA year-on-year change?

Over the past year, MED annual EBITDA has changed by -$56.23 M (-28.73%)

What is Medifast quarterly EBITDA?

The current quarterly EBITDA of MED is $5.30 M

What is the all time high quarterly EBITDA for Medifast?

Medifast all-time high quarterly EBITDA is $62.74 M

What is Medifast quarterly EBITDA year-on-year change?

Over the past year, MED quarterly EBITDA has changed by +$10.11 M (+210.21%)

What is Medifast TTM EBITDA?

The current TTM EBITDA of MED is $23.72 M

What is the all time high TTM EBITDA for Medifast?

Medifast all-time high TTM EBITDA is $226.63 M

What is Medifast TTM EBITDA year-on-year change?

Over the past year, MED TTM EBITDA has changed by -$23.62 M (-49.89%)